Discovery and Development of GS 4104 (oseltamivir) An Orally Active Influenza Neuraminidase Inhibitor

By  

Current Medicinal Chemistry, Vol. 7, Iss. 6, 2000-06 ,pp. : 663-672

Bentham Science Publishers

Access to resources Recommend Favorite

Oseltamivir/zanamivir: Development of neuraminidase inhibitor resistance in influenza A virus H1N1 subtype in a child: case report

By  

Reactions Weekly, Vol. 1, Iss. 1326, 2010-01 ,pp. : 26-27

Adis International

Access to resources Recommend Favorite

Oseltamivir Resistance and the H274Y Neuraminidase Mutation in Seasonal, Pandemic and Highly Pathogenic Influenza Viruses

By Hurt Aeron C.   Holien Jessica K.   Parker Michael W.   Barr Ian G.  

Drugs, Vol. 69, Iss. 18, 2009-12 ,pp. : 2523-2531

Adis International

Access to resources Recommend Favorite

Neuraminidase inhibitor RWJ 270201 prepares to compete in influenza market

By  

Inpharma, Vol. 1, Iss. 1260, 2000-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Identification of new oral dosing regimens for the neuraminidase inhibitor oseltamivir in patients with moderate and severe renal impairment

By  

Clinical Pharmacology In Drug Development, Vol. 2160-763X, Iss. 5, 2015-09 ,pp. : 326-336

John Wiley & Sons Inc

Access to resources Recommend Favorite